Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements (French, HTML)

Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements: French HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-10-28

This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data